OR WAIT null SECS
March 08, 2021
Manufacturing of the vaccine will take place at Baxter’s fill/finish sterile manufacturing facilities located in Bloomington, IN.
March 04, 2021
The European Medicines Agency has begun a rolling review based on laboratory and clinical studies of the Sputnik V (Gam-COVID-Vac).
The European Medicines Agency and Health Canada have published clinical data used to support the authorization of Moderna’s COVID-19 vaccine.
March 03, 2021
With funding from the federal government, Merck will expand capacity to produce J&J’s COVID-19 vaccine.
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
Various strategies to improve bioavailability are being continuously evaluated, affording greater commercial prospects for the future.
RDIF has announced that the Sputnik V vaccine for COVID-19 has been approved in Slovakia under the emergency use authorization procedure.
March 02, 2021
The 3M Polisher ST from 3M Health Care is a single-use anion exchange (AEX) chromatography solution intended to replace the reusable AEX polishing column for biologic drug manufacturing.
FDA moves recommended timeline for API and drug manufacturers to assess impurity risks to March 31, 2021.
March 01, 2021
Distribution of the first one-dose vaccine for COVID-19 to start in early March.
